Skip to content

Public FDA record

Z-1534-2021: VACUETTE Blood Collection tube 9NC Coagulation sodium citrate 3.2% 13x75 blue cap-white ring, sandwich tu

Recall record Z-1534-2021 for Greiner Bio-One North America, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1534-2021
Company in FDA record
Greiner Bio-One North America, Inc.
FDA classification date
May 6, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

VACUETTE Blood Collection tube 9NC Coagulation sodium citrate 3.2% may show insufficient draw volume of the tubes, which could produce erroneous results for prothrombin time, activated partial thromboplastin time, and fibrinogen assays.

Source facts

Action
A Recall notification letter titled, "Urgent Product Recall" was sent to distributors on 03/29/2021 via email and to 19 end users via email on 04/01/2021. First notification mailing to all other end-users will be via UPS. First notification mailing to all other end-users will be via UPS. Assembling the mailing is in-process and the firm will notify FDA on the mailing dates and responses in their next report. Consignees were also notified by phone. The letter instructs the direct consignee to stop using the above-mentioned product (concerned item/lot) immediately and isolate defective products in the consignee facility; assess risks and consequences for the use of this defective product in accordance with the consignee's procedures and take appropriate action; complete the attached Product Disposition Site Confirmation form and fax to Greiner Bio-One North America, Inc. at 800.726.0052 or email to patech@gbo.com. This form is to confirm that the consignees have discarded/destroyed all products from these items/lots. The firm will replace the product after the completed form is sent to Greiner. The notice sent to the distributors instructs them to stop distributing the above-mentioned product (concerned items/lots) immediately and isolate defective products in their facility. Complete the attached Product Disposition form and fax it to Greiner at 800.726.0052 or email to patech@gbo.com. The firm will contact the distributor for the return or destruction of the product after receiving the attached Product Disposition Site Confirmation form. The firm will use this information to send you replacement stock or issue a credit. The firm informs the distributor that it is a legal obligation to notify customers. Therefore, the firm is requesting that the distributor please provide them with a list of their customers that have received the item with this specific lot number. Include: Facility, Address, Key contact, Phone number, Fax, and Date shipped. Please provide this as
Initiated
2021-03-29
Root cause
Process control
Terminated
2023-10-10
Distribution
US Nationwide distribution in the states of KY, TX, LA, OH, AR, IL, SC, PA, FL, NC, AZ, CA, MI, NE, KS, MI, MO, NY, and NJ.
Recall number
Z-1534-2021
Recall status
Terminated
CDRH record ID
186712
FDA classified
2021-05-06
Recall event number
87660

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗